This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Liu SV, Gollard R, Iqbal S.Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab. Journal of Clinical Pharmacy and Therapeutics 37: 607-609, No. 5, Oct 2012. Available from: URL: http://dx.doi.org/10.1111/j.1365-2710.2012.01343.x - USA
Additional information
Key words
adverse reactions; Bevacizumab; drug-induced; Bladder-disorders
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Bevacizumab. React. Wkly. 1426, 13 (2012). https://doi.org/10.2165/00128415-201214260-00046
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214260-00046